Bukalo India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 10 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
as on 16-11-2024
- Revenue 5.68%
(FY 2023)
- Profit -0.13%
(FY 2023)
- Ebitda -269.94%
(FY 2023)
- Net Worth 39.64%
(FY 2023)
- Total Assets 8.79%
(FY 2023)
About Bukalo India
The Corporate was formerly known as Bukalo Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 M.
Sandeep Singh, Devender Singh, and Ravinder Kumar serve as directors at the Company.
- CIN/LLPIN
U52311HR2014PTC052652
- Company No.
052652
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jul 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurugram, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Bukalo India Private Limited offer?
Bukalo India Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, VTM Kit Raw Materials, Nutraceuticals & Dietary Supplements, Whey Protein, Weight Gain Nutrition, Fitness Supplements, Weight Loss Supplement, Common Disease Medicines, Pharmaceutical Capsules, Juices, Soups & Soft Drinks.
Who are the key members and board of directors at Bukalo India?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sandeep Singh | Director | 04-Jul-2014 | Current |
Devender Singh | Director | 04-Jul-2014 | Current |
Ravinder Kumar | Director | 05-Sep-2014 | Current |
Financial Performance of Bukalo India.
Bukalo India Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.68% increase. The company also saw a slight decrease in profitability, with a 0.13% decrease in profit. The company's net worth Soared by an impressive increase of 39.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Bukalo India?
In 2023, Bukalo India had a promoter holding of 70.00% and a public holding of 30.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Lender | Amount | Status |
---|---|---|
State Bank Of India Creation Date: 01 Mar 2016 | ₹1.00 M | Open |
How Many Employees Work at Bukalo India?
Bukalo India has a workforce of 26 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bukalo India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bukalo India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.